121 related articles for article (PubMed ID: 32234540)
1. Effect of antiviral treatment in older patients hospitalized with confirmed influenza.
Soldevila N; Toledo D; Ortiz de Lejarazu R; Tamames S; Castilla J; Astray J; Fernández MA; Martín V; Egurrola M; Morales Suárez-Varela M; Domínguez À;
Antiviral Res; 2020 Jun; 178():104785. PubMed ID: 32234540
[TBL] [Abstract][Full Text] [Related]
2. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.
Domínguez A; Romero-Tamarit A; Soldevila N; Godoy P; Jané M; Martínez A; Torner N; Caylà JA; Rius C;
Epidemiol Infect; 2018 May; 146(7):799-808. PubMed ID: 29606178
[TBL] [Abstract][Full Text] [Related]
4. Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020.
Walsh PS; Schnadower D; Zhang Y; Ramgopal S; Shah SS; Wilson PM
JAMA Pediatr; 2022 Nov; 176(11):e223261. PubMed ID: 36121673
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.
Sharma Y; Horwood C; Hakendorf P; Thompson C
Int J Infect Dis; 2021 Mar; 104():232-238. PubMed ID: 33434667
[TBL] [Abstract][Full Text] [Related]
6. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
Coffin SE; Leckerman K; Keren R; Hall M; Localio R; Zaoutis TE
Pediatr Infect Dis J; 2011 Nov; 30(11):962-6. PubMed ID: 21997661
[TBL] [Abstract][Full Text] [Related]
7. Effect of Early Oseltamivir Treatment on Mortality in Critically Ill Patients With Different Types of Influenza: A Multiseason Cohort Study.
Lytras T; Mouratidou E; Andreopoulou A; Bonovas S; Tsiodras S
Clin Infect Dis; 2019 Nov; 69(11):1896-1902. PubMed ID: 30753349
[TBL] [Abstract][Full Text] [Related]
8. Economic outcomes of influenza in hospitalized elderly with and without ICU admission.
Chan YK; Wong RY; Ip M; Lee NL; You JH
Antivir Ther; 2017; 22(2):173-177. PubMed ID: 27740538
[TBL] [Abstract][Full Text] [Related]
9. Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season.
Soldevila N; Acosta L; Martínez A; Godoy P; Torner N; Rius C; Jané M; Domínguez A;
Sci Rep; 2021 Jun; 11(1):13587. PubMed ID: 34193898
[TBL] [Abstract][Full Text] [Related]
10. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections.
Ramirez J; Peyrani P; Wiemken T; Chaves SS; Fry AM
Clin Infect Dis; 2018 Aug; 67(5):736-742. PubMed ID: 29659754
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Adlhoch C; Delgado-Sanz C; Carnahan A; Larrauri A; Popovici O; Bossuyt N; Thomas I; Kynčl J; Slezak P; Brytting M; Guiomar R; Redlberger-Fritz M; Maistre Melillo J; Melillo T; van Gageldonk-Lafeber AB; Marbus SD; O'Donnell J; Domegan L; Gomes Dias J; Olsen SJ
Euro Surveill; 2023 Jan; 28(4):. PubMed ID: 36700868
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Use in Canadian Children Hospitalized for Influenza.
Mehta K; Morris SK; Bettinger JA; Vaudry W; Jadavji T; Halperin SA; Bancej C; Sadarangani M; Dendukuri N; Papenburg J;
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34548379
[TBL] [Abstract][Full Text] [Related]
14. Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
Doshi S; Kamimoto L; Finelli L; Perez A; Reingold A; Gershman K; Yousey-Hindes K; Arnold K; Ryan P; Lynfield R; Morin C; Baumbach J; Hancock EB; Bennett NM; Zansky S; Thomas A; Schaffner W; Fry AM
J Infect Dis; 2011 Dec; 204(12):1848-56. PubMed ID: 22013219
[TBL] [Abstract][Full Text] [Related]
15. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.
Groeneveld GH; Marbus SD; Ismail N; de Vries JJC; Schneeberger P; Oosterheert JJ; van Dissel JT; de Boer MGJ
Int J Antimicrob Agents; 2020 Nov; 56(5):106155. PubMed ID: 32898685
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.
McGeer A; Green KA; Plevneshi A; Shigayeva A; Siddiqi N; Raboud J; Low DE;
Clin Infect Dis; 2007 Dec; 45(12):1568-75. PubMed ID: 18190317
[TBL] [Abstract][Full Text] [Related]
18. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
Reacher M; Warne B; Reeve L; Verlander NQ; Jones NK; Ranellou K; Christou S; Wright C; Choudhry S; Zambon M; Sander C; Zhang H; Jalal H
Euro Surveill; 2019 Oct; 24(44):. PubMed ID: 31690364
[TBL] [Abstract][Full Text] [Related]
19. Seasonal influenza-associated intensive care unit admission and death in tropical Singapore, 2011-2015.
Zhang ZXZ; Mar Kyaw W; Ho HJ; Tay MZ; Huang H; Aung Hein A; Chow A
J Clin Virol; 2019 Aug; 117():73-79. PubMed ID: 31238274
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Hung IFN; To KKW; Chan JFW; Cheng VCC; Liu KSH; Tam A; Chan TC; Zhang AJ; Li P; Wong TL; Zhang R; Cheung MKS; Leung W; Lau JYN; Fok M; Chen H; Chan KH; Yuen KY
Chest; 2017 May; 151(5):1069-1080. PubMed ID: 27884765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
